Gábor Tóth
Directeur/Membre du Conseil chez International Centre For Genetic Engineering & Biotechnology
Profil
Gábor Tóth is currently a Member-Governors Board at the International Centre For Genetic Engineering & Biotechnology.
Previously, he worked as a Member-Supervisory Board at Chemical Works of Gedeon Richter Plc.
Postes actifs de Gábor Tóth
Sociétés | Poste | Début |
---|---|---|
International Centre For Genetic Engineering & Biotechnology
International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Directeur/Membre du Conseil | - |
Anciens postes connus de Gábor Tóth
Sociétés | Poste | Fin |
---|---|---|
GEDEON RICHTER | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GEDEON RICHTER | Health Technology |
Entreprise privées | 1 |
---|---|
International Centre For Genetic Engineering & Biotechnology
International Centre For Genetic Engineering & Biotechnology Miscellaneous Commercial ServicesCommercial Services The International Centre for Genetic Engineering and Biotechnology is a research organization based in Trieste, Italy. The Italian company offers resources, tools, and know-how to fight the SARS-CoV-2 virus that causes COVID-19 to its member states free of charge. Additionally, the private company promotes international cooperation in developing and applying peaceful uses of genetic engineering and biotechnology, particularly for developing countries. The company's objective is to be the world's leading intergovernmental organization for research, training, and technology transfer in the field of life sciences and biotechnology. The company was founded in 1983, and Lawrence Banks has been the CEO since 2019. | Commercial Services |